Survival for three years after intramyocardial high malignant non-Hodgkin lymphoma

Cardiovasc Surg. 2003 Aug;11(4):321-3. doi: 10.1016/S0967-2109(03)00031-0.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aged
  • Antibiotics, Antineoplastic / therapeutic use
  • Cardiac Output, Low / etiology*
  • Cardiac Output, Low / surgery
  • Combined Modality Therapy
  • Female
  • Heart Neoplasms / drug therapy
  • Heart Neoplasms / surgery*
  • Humans
  • Immune Tolerance
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / surgery*
  • Survivors
  • Ventricular Outflow Obstruction / etiology

Substances

  • Antibiotics, Antineoplastic